The 5-year overall survival rate for the PKM2-/cofilin-1- strongly positive group was very poor (0%), compared with the other two groups (Fig. 3 D), suggesting combination of the two markers may facilitate a more accurate prognosis of lung adenocarcinoma. The gene discussed is CFL1; the disease is lung adenocarcinoma.